[New therapeutic approaches in acute myeloblastic leukemia (AML) and chronic myeloid leukemia (CML)].
Marie
J P
JP
Hôtel-Dieu de Paris, France.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007167:Immunotherapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D014212:Tretinoin / Q000627:therapeutic use
D003115:Colony-Stimulating Factors; D016179:Granulocyte Colony-Stimulating Factor; D014212:Tretinoin
Nouvelles approches thérapeutiques dans la leucémie aiguë myéloblastique (LAM) et la leucémie myéloïde chronique (LMC).